Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contrast Media | 9 | 2025 | 507 | 2.140 |
Why?
|
| Nanoparticles | 5 | 2025 | 288 | 1.770 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2025 | 2163 | 1.020 |
Why?
|
| Aortic Aneurysm | 2 | 2025 | 237 | 0.880 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2020 | 49 | 0.640 |
Why?
|
| Prodrugs | 2 | 2020 | 63 | 0.640 |
Why?
|
| Coumarins | 2 | 2016 | 23 | 0.610 |
Why?
|
| Placenta | 4 | 2025 | 539 | 0.530 |
Why?
|
| Bibenzyls | 1 | 2016 | 1 | 0.490 |
Why?
|
| Naphthalenes | 1 | 2016 | 38 | 0.480 |
Why?
|
| Neoplasms | 3 | 2020 | 2952 | 0.410 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2025 | 3852 | 0.360 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 1829 | 0.360 |
Why?
|
| Aorta | 2 | 2025 | 552 | 0.310 |
Why?
|
| Tubulin | 4 | 2020 | 73 | 0.310 |
Why?
|
| Animals | 14 | 2025 | 34823 | 0.270 |
Why?
|
| Mice | 11 | 2025 | 18488 | 0.230 |
Why?
|
| Moyamoya Disease | 1 | 2025 | 42 | 0.230 |
Why?
|
| Particle Size | 1 | 2025 | 149 | 0.220 |
Why?
|
| Oxidative Phosphorylation | 1 | 2025 | 124 | 0.220 |
Why?
|
| Ferrosoferric Oxide | 1 | 2025 | 28 | 0.220 |
Why?
|
| Photons | 1 | 2025 | 53 | 0.220 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 4683 | 0.220 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2025 | 189 | 0.210 |
Why?
|
| Alzheimer Disease | 2 | 2022 | 865 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 4753 | 0.210 |
Why?
|
| Actins | 1 | 2025 | 334 | 0.200 |
Why?
|
| Placenta Accreta | 1 | 2025 | 169 | 0.190 |
Why?
|
| Triiodobenzoic Acids | 1 | 2021 | 31 | 0.170 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 95 | 0.170 |
Why?
|
| Aortography | 1 | 2021 | 183 | 0.160 |
Why?
|
| Plaque, Amyloid | 1 | 2020 | 70 | 0.160 |
Why?
|
| Amyloid | 1 | 2020 | 70 | 0.160 |
Why?
|
| Stilbenes | 1 | 2020 | 38 | 0.160 |
Why?
|
| Solubility | 2 | 2018 | 125 | 0.160 |
Why?
|
| Aortic Rupture | 1 | 2021 | 119 | 0.160 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2020 | 104 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 215 | 0.150 |
Why?
|
| Fluorine | 1 | 2018 | 15 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2018 | 58 | 0.140 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 351 | 0.140 |
Why?
|
| Mice, SCID | 2 | 2016 | 604 | 0.140 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 590 | 0.130 |
Why?
|
| Tubulin Modulators | 1 | 2015 | 11 | 0.120 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 688 | 0.120 |
Why?
|
| Optical Imaging | 1 | 2016 | 73 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2020 | 749 | 0.110 |
Why?
|
| Drug Design | 1 | 2016 | 161 | 0.110 |
Why?
|
| Water | 1 | 2016 | 195 | 0.110 |
Why?
|
| Breast | 1 | 2016 | 215 | 0.110 |
Why?
|
| Benzocycloheptenes | 1 | 2013 | 1 | 0.110 |
Why?
|
| Cell Line, Tumor | 3 | 2016 | 3687 | 0.100 |
Why?
|
| Amino Acids | 1 | 2016 | 626 | 0.100 |
Why?
|
| Humans | 9 | 2025 | 132055 | 0.080 |
Why?
|
| Pregnancy | 4 | 2025 | 7536 | 0.070 |
Why?
|
| Gadolinium | 2 | 2019 | 116 | 0.070 |
Why?
|
| Liposomes | 2 | 2019 | 203 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 2675 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 111 | 0.070 |
Why?
|
| Female | 7 | 2025 | 70691 | 0.060 |
Why?
|
| Male | 4 | 2025 | 64944 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2022 | 2449 | 0.060 |
Why?
|
| Niacinamide | 1 | 2025 | 31 | 0.060 |
Why?
|
| Polymerization | 2 | 2015 | 15 | 0.060 |
Why?
|
| Glycolysis | 1 | 2025 | 165 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2025 | 238 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 1670 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 69 | 0.050 |
Why?
|
| Cell Movement | 1 | 2025 | 890 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 89 | 0.040 |
Why?
|
| Presenilin-1 | 1 | 2020 | 57 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 88 | 0.040 |
Why?
|
| NADPH-Ferrihemoprotein Reductase | 1 | 2020 | 4 | 0.040 |
Why?
|
| A549 Cells | 1 | 2020 | 49 | 0.040 |
Why?
|
| Colchicine | 1 | 2020 | 39 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2021 | 163 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2021 | 198 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2020 | 101 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2020 | 380 | 0.040 |
Why?
|
| Mitochondria | 1 | 2025 | 751 | 0.040 |
Why?
|
| tau Proteins | 1 | 2022 | 237 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2020 | 133 | 0.040 |
Why?
|
| Blood Volume | 1 | 2019 | 81 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 255 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 42 | 0.040 |
Why?
|
| Placentation | 1 | 2019 | 60 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2018 | 77 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 65 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 623 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2018 | 133 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2025 | 1963 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 1050 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 469 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3863 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2020 | 800 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2015 | 142 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2312 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1227 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2232 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3604 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2013 | 322 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 3403 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 6442 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 2509 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 17367 | 0.010 |
Why?
|
| Adult | 1 | 2025 | 31557 | 0.010 |
Why?
|